Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Enhanced Immunochemistry Analyzers Offer Workstation Consolidation and Efficiency

By LabMedica International staff writers
Posted on 09 Sep 2010
A family of immunochemistry analyzers offers enhanced automation, workstation consolidation, high efficiency, and labor savings for laboratories of all sizes.

The features of the new immunochemistry analyzers, dubbed Architectplus, include more comprehensive and user-friendly software; a smaller size to help reduce space requirements; improvements to streamline operations and reduce interruptions; new video instructions to help with routine maintenance; and an attractive exterior design and styling.

A product of Abbott (Abbott Park, IL, USA), existing Architect systems can be upgraded to Architectplus onsite. More...
The analyzers have an extensive menu of more than 170 assays. Laboratories will be able to reduce labor, optimize throughput, and enhance overall productivity, while standardizing data management processes and optimizing inventory control. The new features will minimize training, and reduce inventory costs and sample contamination potential, resulting in improved performance and outcomes for laboratories, physicians, and patients.

Two new assays recently added were the HE4 for early detection and monitoring of ovarian cancer and the human immunodeficiency virus (HIV) antigen/antibody Combo Assay to identify early HIV infections. Additionally, Abbott has more than a dozen novel biomarkers in development, and several are expected to be introduced within months of the introduction of the analyzers.


"According to the Health and Human Services Administration on Aging, one in five Americans will be age 65 and older in 20 years. It's well documented that older people are the largest consumers of health care services, and the huge growth in this age group will likely generate significant new demand for routine lab tests and follow-up testing for diabetes, cancer and other conditions," said Brian Blaser, senior vice president, diagnostics, Abbott. "Already stressed with finding ways to deal with diminishing resources and a serious shortage of trained staff, laboratories are turning to diagnostics manufacturers for technologies and capabilities they need to operate effectively and survive in this environment."

Architectplus was showcased for the first time at the annual American Association for Clinical Chemistry Lab Expo, which was held in Anaheim, (CA, USA) from July 25-29, 2010.

Related Links:

Abbott
American Association for Clinical Chemistry




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.